StockData
Charles River Laboratories International, Inc. logo

Charles River Laboratories International, Inc. (CRL) stock

CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30225% above fair value
$333.25+1.09 (+0.33%)

Close on Nov 18, 2026Market cap $15.91BP/E –Yield –

Charles River Laboratories International price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Charles River Laboratories International's price to book ratio was 5.1× on Nov 11, 2026, against 2.6× a year earlier. Over the last 5 years it ranged from 1.8× to 7.8×, with a median of 3.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.1×+2.2
2025Dec 31, 20252.9×+0.4
2024Dec 31, 20242.5×−1.2
2023Dec 29, 20233.7×−0.6
2022Dec 30, 20224.2×−3.6
2021Dec 31, 20217.8×+1.3
2020Dec 31, 20206.6×+1.7
2019Dec 31, 20194.9×+0.5
2018Dec 31, 20184.3×−0.7
2017Dec 29, 20175.1×+0.9
2016Dec 30, 20164.2×−1.2
2015Dec 31, 20155.3×+0.9
2014Dec 31, 20144.4×+0.9
2013Jul 31, 20133.5×+0.5
2012Dec 31, 20123.0×+0.5
2011Dec 30, 20112.5×+0.5
2010Dec 31, 20102.0×–

More Charles River Laboratories International figures

See a number that looks wrong?